Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb:15:81-89.
doi: 10.1016/j.ebiom.2016.11.031. Epub 2016 Dec 1.

Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment

Affiliations

Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment

Chung-Feng Huang et al. EBioMedicine. 2017 Feb.

Erratum in

Abstract

Background/aims: The genome-wide association study has shown that MHC class I chain-related A (MICA) genetic variants were associated with hepatitis C virus (HCV) related hepatocellular carcinoma (HCC). The impact of the genetic variants and its serum levels on post-treatment cohort is elusive [corrected].

Methods: MICA rs2596542 genotype and serum MICA (sMICA) levels were evaluated in 705 patients receiving antiviral therapy.

Results: Fifty-eight (8·2%) patients developed HCC, with a median follow-up period of 48·2 months (range: 6–129 months). The MICA A allele was associated with a significantly increased risk of HCC development in cirrhotic non-SVR patients but not in patients of non-cirrhotic and/or with SVR. For cirrhotic non-SVR patients, high sMICA levels (HR/CI: 5·93/1·86–26·38, P = 0·002) [corrected] and the MICA rs2596542 A allele (HR/CI: 4·37/1·52–12·07, P = 0·002) were independently associated with HCC development. The risk A allele or GG genotype with sMICA > 175 ng/mL provided the best accuracy (79%) and a negative predictive value of 100% in predicting HCC.

Conclusions: Cirrhotic patients who carry MICA risk alleles and those without risk alleles but with high sMICA levels possessed the highest risk of HCC development once they failed antiviral therapy.

Keywords: EGF; HCC; IL-28; MICA; PNPLA3; SNP; SVR; Treatment; sMICA.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flow chart of the patients.
Fig. 2
Fig. 2
Association of MICA rs2596542 genotype with HCC development stratified by the SVR and cirrhotic status. Risk allele: AA + AG genotype. Non-A allele: GG genotype.
Fig. 3
Fig. 3
sMICA levels in patients with or without HCC development stratified by SVR status.
Fig. 4
Fig. 4
sMICA levels of different MICA SNPs among LC non-SVR patients with or without HCC.
Fig. 5
Fig. 5
HCC development in non-SVR LC patients with different MICA SNP and sMICA levels.

References

    1. Abu Dayyeh B.K., Yang M., Fuchs B.C., Karl D.L., Yamada S., Sninsky J.J. A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma. Gastroenterology. 2011;141(1):141–149. - PMC - PubMed
    1. Asahina Y., Tsuchiya K., Nishimura T., Muraoka M., Suzuki Y., Tamaki N. Alpha-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C. Hepatology (Baltimore, Md) 2013;58(4):1253–1262. - PubMed
    1. Bruix J., Sherman M. Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md) 2011;53(3):1020–1022. - PMC - PubMed
    1. Fabris C., Falleti E., Cussigh A., Bitetto D., Fontanini E., Bignulin S. IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC. J. Hepatol. 2011;54(4):716–722. - PubMed
    1. Goto K., Kato N. MICA SNPs and the NKG2D system in virus-induced HCC. J. Gastroenterol. 2015;50(3):261–272. - PubMed

MeSH terms

Substances